
Stroke trial presentations accepted for prestigious international conference
Argenica Therapeutics, the WA based biotechnology company developing novel therapeutics to reduce brain tissue death after stroke and other acute...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research group
Saumya Heendeniya is a PhD candidate in the Precision Nucleic Acid Therapeutics Research group, led by A/Prof Rakesh N. Veedu, working on mRNA therapeutics. Currently he is working on designing a therapeutic platform for spinal muscular atrophy (SMA).
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.